Lexaria Bioscience Corp. (LEXX)
0.619
+0.02
(+2.76%)
USD |
NASDAQ |
May 14, 14:31
Lexaria Bioscience Gross Profit (TTM) : 0.2804M for Feb. 28, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| CannaPharmaRx, Inc. | -2.085M |
| InMed Pharmaceuticals, Inc. | 0.5836M |
| Target Group, Inc. (Canada) | 1.170M |
| Tilray Brands, Inc. | 203.46M |
| NervGen Pharma Corp. | -0.0399M |